US2016303006A1PendingUtilityA1

Dispersed capsules in lyotropic or lyotropic liquid crystal surfactant phases for enhanced capsule deposition

Assignee: INT FLAVORS & FRAGRANCES INCPriority: Nov 27, 2012Filed: Jul 5, 2016Published: Oct 20, 2016
Est. expiryNov 27, 2032(~6.3 yrs left)· nominal 20-yr term from priority
A61K 8/92A61K 8/416C11D 3/505A61Q 13/00C11B 9/00A61Q 5/12A61K 2800/56A61Q 19/10A61K 8/466A61K 8/11A61K 8/39A61K 8/42A61K 8/0295A61K 8/342A61K 8/463A61K 8/84A61Q 5/02
54
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention is a fragrance containing capsule composition dispersed into a lyotropic liquid crystalline surfactant phase as well as a consumer product base containing the same.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A composition comprising fragrance containing capsules dispersed into a lyotropic liquid crystalline surfactant phase, wherein the lyotropic liquid crystalline surfactant phase is an oil-continuous liquid crystalline phase. 
     
     
         2 . The composition of  claim 1 , wherein the oil-continuous liquid crystalline phase comprises an anionic surfactant and cationic surfactant. 
     
     
         3 . The composition of  claim 2 , wherein the anionic surfactant comprises a sodium dioctylsulfosuccinate, sodium ditridecylsulfosuccinate, sodium didecylsulfosuccinate, sodium bis-tridecyl sulfosuccinate, sodium benzene alkyl sulphonate, or blends thereof. 
     
     
         4 . The composition of  claim 2 , wherein the cationic surfactant comprises dioleoyl ammonium methosulfate, methyl bis(hydrogenated tallow amidoethyl)-2-hydroxyethyl ammonium methyl sulfate, methyl bis(tallow amidoethyl)-2-hydroxyethyl ammonium methyl sulfate, methyl bis(soya amidoethyl)-2-hydroxyethyl ammonium methyl sulfate, methyl bis(canola amidoethyl)-2-hydroxyethyl ammonium methyl sulfate, methyl bis(tallowamido ethyl)-2-tallow imidazolinium methyl sulfate, dioleoyl ammonium methosulfate, dipalmityl ammonium methosulfate, or blends thereof. 
     
     
         5 . The composition of  claim 2 , wherein the anionic surfactant is sodium bis-tridecyl sulphosuccinate and the cationic surfactant is dioleoyl ammonium methosulfate. 
     
     
         6 . The composition of  claim 2 , wherein the anionic surfactant is sodium dioctyl sulfosuccinate and the cationic surfactant is methyl bis (Soya amidoethyl) hydroxyethlyl ammonium methyl sulfate. 
     
     
         7 . The composition of  claim 2 , wherein the anionic surfactant is sodium dioctyl sulfosuccinate and the cationic surfactant is dipalmityl ammonium methosulfate. 
     
     
         8 . The composition of  claim 1 , wherein the capsules are microcapsules, microparticles, nanoparticles, liposomes, vesicles, spores or a combination thereof. 
     
     
         9 . The composition of  claim 8 , wherein the microcapsules comprise urea-formaldehyde, melamine-formaldehyde, phenolic-formaldehyde, urea-glutaraldehyde, melamine-glutaraldehyde, phenolic-glutaraldehyde, polyurea, polyurethane, silica or a silica-derived material, or combinations thereof. 
     
     
         10 . The composition of  claim 8 , wherein the microcapsules comprise polyurea, polyurethane, or a combination thereof. 
     
     
         11 . The composition of  claim 8 , wherein the microcapsules are acrylate-based hydrogel core-shell capsules, polyurea/polyurethane-acrylic hybrid core-shell capsules, or polyamide and polyester-based capsules. 
     
     
         12 . The composition of  claim 8 , wherein the microcapsules are polyamide and polyester-based capsules. 
     
     
         13 . The composition of  claim 8 , wherein the microcapsules comprise silica or silica-derived materials. 
     
     
         14 . The composition of  claim 8 , wherein the microcapsules are physically or chemically coated with a polymer that facilitates incorporation of the microcapsules into the surfactant phase. 
     
     
         15 . The composition of  claim 8 , wherein the microcapsules or nanoparticles comprise polyethylene, poly vinyl acetate, ethylene-vinyl acetate copolymers, polyacrylate, polyurethane, polyurea, formaldehyde resin, polyester, or polyamide. 
     
     
         16 . The composition of  claim 8 , wherein the spores are plant spores optionally coated with a polymer. 
     
     
         17 . The composition of  claim 8 , wherein the vesicles are polymersomes. 
     
     
         18 . A consumer product comprising the composition of  claim 1 . 
     
     
         19 . The consumer product of  claim 18 , wherein said product is prepared by
 (a) mixing a non-organized surfactant phase with a dispersion comprising fragrance containing capsules, and   (b) adding said mixture to a consumer product thereby forming a consumer product with fragrance containing capsules dispersed into a lyotropic liquid crystalline surfactant phase.   
     
     
         20 . The consumer product of  claim 18 , wherein said product is prepared by mixing a consumer product with fragrance containing capsules dispersed into a lyotropic liquid crystalline surfactant phase. 
     
     
         21 . The consumer product of  claim 18 , further comprising a cationic or amphoteric polymer, or blend thereof.

Join the waitlist — get patent alerts

Track US2016303006A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.